Clariane : CA T2 conforme / Résultat S1 plutôt dans le haut de fourchette : biais rassurant sur les marges (tous les pays se tiennent bien sauf la France)
>S1 plutôt meilleur qu’attendu, sauf sur le RN - Clariane publie un CA T2 à 1327 M€ (soit +4,7% et +6,2%e organique), soit 2636 M€ à fin juin (ie. +6,1% et +6,8% organique). Les résultats S1 ressortent ainsi : EBITDA à 518 M€, EBIT à 125 M€ (et le RN IFRS à -52 M€ vs 1 M€ (-28 M€ vs 26 M€ pré-IFRS 16). Le ratio de levier financier s’améliore de 50 pb, à 3,6x, contre 4,1x au 30 juin 2023 (et 3,8x fin 2023). Clariane confirme ses objectifs 2024, à savoir un CA en hausse...Korian is an actor on the temporary and permanent dependency care market in France, Germany and Italy. Co. offers and develops services related to dependency through its retirement homes (116 as of Dec 31 2009), follow-up care and rehabilitation facilities (35 as of Dec 31 2009) and psychiatric clinics (11 as of Dec 31 2009). Co.'s operations can be divided into four geographical segments: Medical and Social activity in France (retirement homes); Sanitary activity in France (follow-up care, rehabilitation, psychiatry and home medical care); Italy; and Germany.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.